# AI-Assisted Adaptive Clinical Trial for Early Treatment Failure in Type 2 Diabetes

##  Project Overview

This project presents an **AI-assisted adaptive clinical trial framework** designed to identify and respond to **early treatment failure in patients with Type 2 Diabetes Mellitus (T2DM)**. The study integrates **machine learning‚Äìbased risk prediction**, **adaptive trial design**, and **real-world data simulation** to improve personalized treatment decision-making and trial efficiency.

Traditional clinical trials in diabetes often rely on static treatment allocation and population-level outcomes. This project demonstrates how **artificial intelligence can be embedded within an adaptive trial framework** to dynamically stratify risk, guide treatment adjustments, and compare outcomes between conventional and AI-adaptive trial arms.

---

##  Objectives

The project is guided by the following objectives:

1. To develop an AI-driven adaptive clinical trial framework that integrates wearable biomarker data (e.g., continuous glucose, heart rate variability, physical activity) to predict early treatment failure in Type 2 diabetes patients.
2. To evaluate the feasibility and data quality of a decentralized clinical trial model using mobile health technologies in Sub-Saharan African healthcare settings.
3. To assess whether AI-assisted real-time treatment adjustments reduce time to therapeutic optimization compared to conventional fixed-protocol clinical trials.

---

##  Methodology

* **Study Design:** Simulated adaptive clinical trial
* **Data:** Synthetic dataset representing 1,000 participants with Type 2 Diabetes
* **Features:** Clinical variables, behavioral indicators, and simulated wearable-derived metrics
* **Modeling Approach:** Machine learning classification for early treatment failure prediction
* **Trial Arms:**

  * Conventional control arm (static treatment)
  * AI-adaptive arm (risk-based treatment adjustment)

The adaptive framework uses model-predicted risk levels to guide treatment escalation or optimization during the simulated trial.

---

##  Key Components

* Data preprocessing and feature engineering
* Machine learning model development and evaluation
* Risk stratification (low, moderate, high risk)
* Adaptive treatment allocation logic
* Comparative analysis of trial outcomes

---

##  Repository Structure

```
nicholasmwanza/ClinicalTrials
‚îÇ
‚îú‚îÄ‚îÄ AI-Assisted Adaptive Clinical Trial for Early Treatment Failure in Type 2 Diabetes(3).ipynb
‚îú‚îÄ‚îÄ README.md
‚îú‚îÄ‚îÄ clinical_data.csv                
‚îú‚îÄ‚îÄ clinical_data_scored.csv/             
‚îî‚îÄ‚îÄ                
```

--

##  Tools and Technologies

* Python
* Jupyter Lab
* Pandas
* NumPy
* Scikit-learn
* Matplotlib / Seaborn

---

##  Expected Outcomes

* Improved identification of patients at risk of early treatment failure
* Reduced failure rates in the AI-adaptive trial arm
* Demonstration of the feasibility of integrating AI into adaptive clinical trial designs
* Contribution to precision medicine and data-driven clinical research

---

## ‚ö†Ô∏è Disclaimer

* This project is **for academic and research purposes only**.
* The data used are **synthetic** and do not represent real patients.
* The framework is **not intended for direct clinical use** without proper validation and regulatory approval.



---

##  Author

**Nicholas Mwanza**

Applied Statistician/ Data Science, Public Health Practitioner, 
AI-Assisted Clinical Trial Research

---

## üìÑ License

This project is released under the **MIT License**.

---


